Michael J. Thomas

10.0k citations
148 papers · 8.2k · 4 hit papers · h-index 47

Impact in

Papers in

    • Diabetes, Cardiovascular Risks, and Lipoproteins 22
    • Growth Hormone and Insulin-like Growth Factors 9
    • Cholesterol and Lipid Metabolism 29
    • Lipoproteins and Cardiovascular Health 8

Michael J. Thomas

145 papers receiving 8.0k citations

Michael J. Thomas's Hit Papers

Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC 2024 · 250 citations
2500+7+14Years since publication100200300400500

Peers

Michael J. Thomas
Comparison fields: 5 of 161
  • Internal Medicine 392
  • Endocrinology, Diabetes and Metabolism 1.4k
  • Oncology 1.6k
  • Immunology 1.3k
  • Cancer Research 692
Replace Leonard Kritharides with:
Leonard Kritharides Australia
David B. Sacks United States
Jane E. Freedman United States
Dietrich Seidel Germany
Aaron J. Marcus United States
Petr Jarolı́m United States
Victor W. Armstrong Germany
J. Fraser Mustard Canada
Zuyi Yuan China
Vicente Vicente Spain
Michael J. Thomas relative to Leonard Kritharides Australia Leonard Kritharides's profile →
Citations per field
00.5×1.5×2×2.4×
Leonard Kritharides · 1×
Citations per year

Countries citing papers authored by Michael J. Thomas

Since Specialization
Citations

This map shows the geographic impact of Michael J. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Thomas more than expected).

Fields of papers citing papers by Michael J. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Thomas. The network helps show where Michael J. Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Thomas Line = papers co-authored together Michael J. Thomas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
Hit paper breakdown →
2004552
2
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Hit paper breakdown →
2018496
3
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
Hit paper breakdown →
2016440
4 2011296
5 2010288
6 2013277
7 1988260
8
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
Hit paper breakdown →
2024250
9 2017226
10 2000188
11 2002166
12 2012145
13 2016144
14 2018143
15 2008120
16 2019119
17 2010118
18 2009110
19 2007107
20 2012106

About Michael J. Thomas

Michael J. Thomas is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Biochemistry, Molecular Biology and Immunology, having authored 148 papers that have together received 8.2k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers), Peroxisome Proliferator-Activated Receptors (18 papers), Atherosclerosis and Cardiovascular Diseases (11 papers), Growth Hormone and Insulin-like Growth Factors (9 papers), Lipid Membrane Structure and Behavior (8 papers), Lipid metabolism and biosynthesis (8 papers) and Lipoproteins and Cardiovascular Health (8 papers). The work is most often cited by research in Internal Medicine (392 citations), Endocrinology, Diabetes and Metabolism (1.4k citations), Oncology (1.6k citations), Immunology (1.3k citations) and Cancer Research (692 citations). Michael J. Thomas has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Mary G. Sorci‐Thomas, John A. Thomas, Shaila Bhat, John S. Parks, John S. Owen, Michael P. Samuel, Xuewei Zhu, Peter S. Rotwein, Gwendalyn J. Randolph and Joseph T. O’Flaherty. Their work appears in journals such as Journal of Lipid Research, Journal of Biological Chemistry, Biochemistry, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact